SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Donna Mae Lyn Buhat, Eng-King Tan, Genetic testing of LRRK2 in Parkinson's disease: is there a clinical role?, Parkinsonism & Related Disorders, 2014, 20, S54

    CrossRef

  2. 2
    Jean-Marc Burgunder, Genetics of Huntington's disease and related disorders, Drug Discovery Today, 2014, 19, 7, 985

    CrossRef

  3. 3
    Georgios Koutsis, Georgia Karadima, Athina Kladi, Marios Panas, Late-onset Huntington's disease: Diagnostic and prognostic considerations, Parkinsonism & Related Disorders, 2014, 20, 7, 726

    CrossRef

  4. You have free access to this content4
    A. Berardelli, G. K. Wenning, A. Antonini, D. Berg, B. R. Bloem, V. Bonifati, D. Brooks, D. J. Burn, C. Colosimo, A. Fanciulli, J. Ferreira, T. Gasser, F. Grandas, P. Kanovsky, V. Kostic, J. Kulisevsky, W. Oertel, W. Poewe, J.-P. Reese, M. Relja, E. Ruzicka, A. Schrag, K. Seppi, P. Taba, M. Vidailhet, EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  5. 5
    Yaimeé Vázquez-Mojena, Leonides Laguna-Salvia, José M. Laffita-Mesa, Yanetza González-Zaldívar, Luis E. Almaguer-Mederos, Roberto Rodríguez-Labrada, Dennis Almaguer-Gotay, Pedro Zayas-Feria, Luis Velázquez-Pérez, Genetic features of Huntington disease in Cuban population: Implications for phenotype, epidemiology and predictive testing, Journal of the Neurological Sciences, 2013, 335, 1-2, 101

    CrossRef

  6. 6
    R. Krüger, C. Klein, Genetik der Parkinson-Krankheit, medizinische genetik, 2013, 25, 2, 215

    CrossRef

  7. 7
    Mohammad Taghi Akbari, Zahra Zand, Gholam Ali Shahidi, Mohammad Hamid, Clinical Features,DYT1Mutation Screening and Genotype-Phenotype Correlation in Patients with Dystonia from Iran, Medical Principles and Practice, 2012, 21, 5, 462

    CrossRef

  8. You have free access to this content8
    S. Sorbi, J. Hort, T. Erkinjuntti, T. Fladby, G. Gainotti, H. Gurvit, B. Nacmias, F. Pasquier, B. O. Popescu, I. Rektorova, D. Religa, R. Rusina, M. Rossor, R. Schmidt, E. Stefanova, J. D. Warren, P. Scheltens, EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia, European Journal of Neurology, 2012, 19, 9
  9. 9
    Morten Ziebell, Birgitte B. Andersen, Gerda Thomsen, Lars H. Pinborg, Merete Karlsborg, Steen G. Hasselbalch, Gitte M. Knudsen, Predictive value of dopamine transporter SPECT imaging with [123I]PE2I in patients with subtle parkinsonian symptoms, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 2, 242

    CrossRef

  10. 10
    A. H. V. Schapira, Challenges to the development of disease-modifying therapies in Parkinson’s disease, European Journal of Neurology, 2011, 18,
  11. 11
    Christine Klein, Ana Djarmati, Parkinson disease: Genetic testing in Parkinson disease—who should be assessed?, Nature Reviews Neurology, 2011, 7, 1, 7

    CrossRef

  12. 12
    Sarah Jesse, Johannes Brettschneider, Sigurd D. Süssmuth, Bernhard G. Landwehrmeyer, Christine A. F. Arnim, Albert C. Ludolph, Hayrettin Tumani, Markus Otto, Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases, Journal of Neurology, 2011, 258, 6, 1034

    CrossRef

  13. 13
    Susanne A. Schneider, Christine Klein, What Is the Role of Genetic Testing in Movement Disorders Practice?, Current Neurology and Neuroscience Reports, 2011, 11, 4, 351

    CrossRef

  14. 14
    Corrigendum, European Journal of Neurology, 2010, 17, 2
  15. You have free access to this content15
    T. Gasser, J. Finsterer, J. Baets, C. Van Broeckhoven, S. Di Donato, B. Fontaine, P. De Jonghe, A. Lossos, T. Lynch, C. Mariotti, L. Schöls, A. Spinazzola, Z. Szolnoki, S. J. Tabrizi, C.M.E. Tallaksen, M. Zeviani, J-M. Burgunder, H. F. Harbo, EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias, European Journal of Neurology, 2010, 17, 2
  16. 16
    George D Mellick, Peter A Silburn, Greg T Sutherland, Gerhard A Siebert, Exploiting the potential of molecular profiling in Parkinson’s disease: current practice and future probabilities, Expert Review of Molecular Diagnostics, 2010, 10, 8, 1035

    CrossRef

  17. 17
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  18. 18
    Norbert Brüggemann, Christine Klein, Genetics of Primary Torsion Dystonia, Current Neurology and Neuroscience Reports, 2010, 10, 3, 199

    CrossRef

  19. 19
    Neurology in the European Journal of Neurology, European Journal of Neurology, 2010, 17, 12
  20. 20
    E. K. Tan, A. H. Schapira, Summary of GIGYF2 studies in Parkinson’s disease: the burden of proof, European Journal of Neurology, 2010, 17, 2
  21. 21
    Fenna T. Phibbs, Peter Hedera, UPDATE ON THE GENETICS OF MOVEMENT DISORDERS, CONTINUUM: Lifelong Learning in Neurology, 2010, 16, 77

    CrossRef

  22. 22
    Thomas Gasser, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef